Page 52 - OR-1-1

3.2. Systems biology-driven organoid modeling between multi-omics data and computational models is
reshaping organoid research, advancing both fundamental
The integration of systems biology into organoid 49,59
research has enabled a deeper understanding of complex biology and therapeutic applications.
47
biological processes. By leveraging multi-omics data, 4. Technological advances empowering
including genomics, transcriptomics, proteomics, and organoids
metabolomics, researchers can comprehensively map
molecular pathways involved in organoid formation and 4.1. AI and machine learning (ML)
48
function. Computational modeling plays a pivotal role AI, including its subset ML, is revolutionizing organoid
in this endeavor by translating vast datasets into predictive research by enabling more efficient and precise analysis
models. These models simulate organ development, of complex biological data. AI-driven algorithms,
49
60
enabling the identification of critical regulatory networks particularly ML models, play a crucial role in automating
and potential points of intervention in disease processes. the identification and quantification of organoid features,
50
This predictive capacity is particularly valuable for studying such as morphology, differentiation status, and functional
developmental disorders, cancer progression, and tissue- properties, through advanced image analysis. 61-63 These
specific pathologies. 16,51
techniques accelerate the evaluation process by interpreting
Single-cell sequencing technologies further enhance large, complex datasets generated from high-content
organoid systems biology by uncovering cellular imaging, biochemical assays, and gene expression profiles,
heterogeneity and lineage-specific differentiation patterns significantly reducing the reliance on manual inspection
within organoids. 52-54 Single-cell RNA sequencing and human intervention. 24
(scRNA-seq) and spatial transcriptomics form a
complementary technological framework for dissecting ML, a subset of AI, is particularly powerful in uncovering
organoid heterogeneity. ScRNA-seq provides single-cell hidden patterns and associations within datasets that
64
resolution to uncover transcriptional diversity, enabling may be missed by traditional analytical methods. ML
precise identification of rare cell subsets and dynamic models can be trained to recognize subtle variations in
differentiation trajectories. However, its dissociation organoid structure or behavior, which helps in a more
process disrupts spatial information, limiting insights accurate assessment of organoid quality, differentiation
65
into microenvironmental interactions and functional progress, and functional responses. In addition, ML
zonation. In contrast, spatial transcriptomics preserves can be utilized in predictive modeling, where it forecasts
spatial coordinates in situ, mapping topological gene organoid responses to different experimental conditions,
expression patterns to elucidate polarized distribution and such as microenvironment changes, nutrient availability,
66
regionalized functional modules. However, its resolution or drug treatments. This predictive capability enhances
is constrained by technical limitations, such as mixed experimental design and optimizes resource allocation
cellular signals per spot and reduced sensitivity to low- by anticipating outcomes before carrying out full-scale
abundance cell populations. Integrating both technologies experiments.
allows multi-dimensional analysis of “cell type-spatial Furthermore, AI and ML can integrate diverse
localization-functional regulation.” Future advancements data sources, including multi-omics data (genomics,
in high-resolution spatial technologies and multi-omics proteomics, etc.) and organoid-based disease models,
integration will enhance the precision of organoid models offering comprehensive insights into underlying biological
in simulating native tissues, offering comprehensive mechanisms and therapeutic efficacy. In the context of
67
technical support for disease mechanism exploration drug discovery, ML algorithms can be employed to screen
and personalized therapeutic development. This granular large compound libraries and predict their effects on
view facilitates the tracking of cell fate decisions and the organoid models, thereby accelerating the identification
mapping of organoid growth trajectories. In addition, of promising drug candidates. Ultimately, AI and ML
55
68
network-based approaches enable the study of cell-cell technologies enable more efficient research workflows,
communication and inter-tissue interactions within enhance the reproducibility of experiments, and improve
complex organoid models. For example, neural and the predictive power of organoid models in biomedical
56
vascular organoid co-culture systems allow the investigation applications.
of neurovascular coupling and tissue homeostasis. 57
4.2. Organoids bioprinting and biofabrication
Systems-level insights also inform the optimization
of organoid culture conditions. By linking molecular Additive manufacturing techniques, particularly 3D
signatures with functional outcomes, researchers can refine bioprinting, have emerged as a transformative tool for the
protocols to produce organoids with more consistent and construction of organoids, offering unprecedented control
physiologically relevant features. Ultimately, the synergy over the spatial arrangement of cells and biomaterials. By
69
58
Volume 1 Issue 1 (2025) 5 doi: 10.36922/OR025040007